Top Markets
#1 0G 0G +24.46%
#2 SAFEcoin SAFEcoin +20.96%
#3 Axelar Axelar +20.82%
#4 Cysic Cysic +20.26%
#5 Full Moon Full Moon +18.98%
#6 Zora Zora +17.42%
#7 AI XOVIA AI XOVIA +17.19%
#8 Merlin's Seal BTC Merlin's Seal BTC +16.94%
#9 VVS Finance VVS Finance +15.88%
#10 Apertum Apertum +13.94%
Coin of the day
0G 0G
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Clasificación en acciones #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Precio por acción
$4.51
Capitalización bursátil
$540.82M
Cambio (1 día)
-2.42%
Cambio (1 año)
-43.50%
País
CN
Comercio Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Categoría

Healthcare
Ratio P/S de Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Nanjing Hicin Pharmaceutical Co., Ltd., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Nanjing Hicin Pharmaceutical Co., Ltd. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.73 -
IN